跳轉至內容
Merck
全部照片(1)

重要文件

查看所有文件

46527

Supelco

炔诺酮乙酸酯

VETRANAL®, analytical standard

同義詞:

17α-乙炔基-17β-羟基-19-去甲-4-雄甾烯-3-酮 17-乙酸酯, 17α-乙炔基-19-去甲睾酮 17β-乙酸酯, 17-羟基-19-去甲-17α-孕甾-4-烯-20-炔基-3-酮 乙酸酯, 去甲基脱氢羟孕酮 17-乙酸酯

登入查看組織和合約定價
全部照片(1)

About This Item

經驗公式（希爾表示法）:
C22H28O3
CAS號碼:
51-98-9
分子量：:
340.46
EC號碼:
200-132-0
MDL號碼:
MFCD00271615
分類程式碼代碼:
41116107
PubChem物質ID:
329757206
NACRES:
NA.24

等級

analytical standard

品質等級

100

產品線

VETRANAL®

儲存期限

limited shelf life, expiry date on the label

技術

HPLC: suitable
gas chromatography (GC): suitable

應用

pharmaceutical (small molecule)

形式

neat

SMILES 字串

CC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C

InChI

1S/C22H28O3/c1-4-22(25-14(2)23)12-10-20-19-7-5-15-13-16(24)6-8-17(15)18(19)9-11-21(20,22)3/h1,13,17-20H,5-12H2,2-3H3/t17-,18+,19+,20-,21-,22-/m0/s1

InChI 密鑰

IMONTRJLAWHYGT-ZCPXKWAGSA-N

基因資訊

human ... PGR(5241)

尋找類似的產品？ 前往 產品比較指南

應用

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

法律資訊

VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到適合的產品？  

試用我們的產品選擇工具.

象形圖

Health hazardEnvironment
GHS08,GHS09

訊號詞

Danger

危險分類

Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 2 - Lact. - Repr. 1A

儲存類別代碼

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves

從最近期的版本中選擇一個：

分析證明 (COA)

Lot/Batch Number
BCCC6456
BCBW5188
BCBV3532
BCBT8602

未看到正確版本？

如果您需要一個特定的版本，您可以透過批號來尋找特定憑證。

搜尋 COA

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Donita Africander et al.
Contraception, 84(4), 423-435 (2011-09-17)
Medroxyprogesterone acetate (MPA) and norethisterone (NET) and its derivatives are widely used in female reproductive therapy, but little is known about their mechanisms of action via steroid receptors in the female genital tract. MPA used as a contraceptive has been
E Lundström et al.
Maturitas, 70(4), 361-364 (2011-10-01)
To determine the effects of continuous combined hormone therapy, tibolone, black cohosh, and placebo on digitized mammographic breast density in postmenopausal women. A prospective, double-blind, placebo-controlled study of 154 postmenopausal women randomized to estradiol 2 mg/norethisterone acetate 1 mg (E2/NETA)
Eija Pöllänen et al.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 20(5), 372-379 (2010-08-21)
To investigate the effects of combined hormone replacement therapy (HRT) and its effective agents on the IGF-1 signaling pathway. To examine the effects of HRT on skeletal muscle in vivo, we utilized pre- and post-intervention samples from a randomized double
Anieta M Sieuwerts et al.
Molecular oncology, 5(6), 504-516 (2011-10-01)
Risk assessment of future breast cancer risk through exposure to sex steroids currently relies on clinical scorings such as mammographic density. Knowledge about the gene expression patterns in existing breast cancer tumors may be used to identify risk factors in
Simone Ferrero et al.
Reproductive biology and endocrinology : RB&E, 9, 88-88 (2011-06-23)
When aromatase inhibitors are used to treat premenopausal women with endometriosis, additional drugs should be used to effectively down-regulate gonadal estrogen biosynthesis. This randomized prospective open-label study compared the efficacy in treating pain symptoms and the tolerability of letrozole combined
查看所有相關論文

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務